Non-Proteinogenic Amino Acid Containing Nucleotide Prodrug to Improve Oral Delivery of a Hepatitis C Virus Treatment

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00620-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Arsinothricin, an Arsenic-Containing Non-Proteinogenic Amino Acid Analog of Glutamate, Is a Broad-Spectrum Antibiotic

Communications Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgricultural
2019English

A Proof-Reading Mechanism for Non-Proteinogenic Amino Acid Incorporation Into Glycopeptide Antibiotics

Chemical Science
Chemistry
2019English

Pseudomonas Fluorescens SBW25 Produces Furanomycin, a Non-Proteinogenic Amino Acid With Selective Antimicrobial Properties

BMC Microbiology
Microbiology
2013English

Hepatitis C Virus Treatment Update

Sohag Medical Journal
2019English

Correction: Pseudomonas Sfluorescens SBW25 Produces Furanomycin, a Non-Proteinogenic Amino Acid With Selective Antimicrobial Properties

BMC Microbiology
Microbiology
2013English

Prodrug Approaches to Improving the Oral Absorption of Antiviral Nucleotide Analogues

Expert Opinion on Drug Delivery
Pharmaceutical Science
2009English

Improvement in the Amino Acid Imbalance in Hepatitis C Virus Infected Patients After Viral Eradication by Interferon Treatment

Hepatitis Monthly
HepatologyInfectious Diseases
2016English

Novel Nucleotide and Amino Acid Covariation Between the 5′UTR and the NS2/NS3 Proteins of Hepatitis C Virus: Bioinformatic and Functional Analyses

PLoS ONE
Multidisciplinary
2011English

Is Response to Anti–hepatitis C Virus Treatment Predictive of Mortality in Hepatitis C Virus/HIV-positive Patients?

AIDS
Infectious DiseasesAllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy